Setmelanotide: Moreover, An MC4R agonist approved for selected rare genetic obesity disorders
These medications potently and selectively inhibit the enzymatic activity of DPP-4, enhancing the effectiveness of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), which are the primary incretins (endogenous glucoregulatory peptides, [39,40,41])
Although the relationship between systemic conditions and PFPT has been suggested in several reported cases, the etiology and pathogenesis of this entity are not yet clearly defined
In the following section, we highlight recent advances in therapeutic approaches that exploit zinc biology, including studies that use zinc as a pharmacological modulator of intracellular organelles and nanotechnology-based zinc materials to mitigate organelle stress
1017,1018 These trials examine combinations such as everolimus for renal cancer (NCT 03163667), talazoparib or palbociclib for solid tumors (NCT 03875313, NCT 03965845), paclitaxel for triple-negative breast cancer (NCT 03057600), azacitidine for myelodysplastic syndromes (NCT 03047993), and cabozantinib for metastatic renal cancer (NCT 03428217)
doi: 10.1212/WNL.0000000000012142 137 SubashiniDDineshaTRSriramaRBBoobalanJPoongulaliSChitraDAet al
